ヨウ化ナトリウム[131I]市場：タイプ、製品形態、製造方法、用途、最終用途産業別-2025-2030年世界予測

ヨウ化ナトリウム[131I]市場は、2024年には7億3,680万米ドルとなり、2025年には7億7,902万米ドル、CAGR 5.94%で成長し、2030年には10億4,182万米ドルに達すると予測されています。

ヨウ化ナトリウム[131I]は、現代の核医学と産業応用において極めて重要な役割を果たし、治療と診断の両分野で転換期を迎えています。精密介入への需要が高まるにつれ、この放射性同位元素は放射性医薬品製剤や様々な研究イニシアチブにおいて不可欠な要素となっています。最近の技術と規制措置の進歩は、製造方法の信頼性を強化し、品質と安全性の両方が最高の国際基準を満たすことを保証しています。

今日のダイナミックな環境において、利害関係者は伝統的な方法論と革新的な製造技術を融合させた変革を目の当たりにしています。ヨウ化ナトリウム[131I]の進化は、業界におけるより広範な動向、すなわち臨床の卓越性と産業の信頼性を支える、より効率的で安全かつコスト効率の高い手法へのシフトを反映しています。この包括的な分析では、画像診断、放射線治療、科学研究におけるヨウ化ナトリウム[131I]の多面的な役割を探る。各開発は、業界成長の勢いを維持するための技術統合と規制の進歩の重要性を強調しています。

さらに、進化する市場力学に関する洞察は、厳格な品質管理と進歩的な研究を組み合わせた統合的アプローチが、ヨウ化ナトリウム[131I]の生産と応用の両方を劇的に強化できることを示唆しています。この入門的概要は、市場セグメンテーション、地域動向、企業の戦略的イニシアチブに関する以降の分析を理解するために必要な背景を提供するものです。

生産、応用、市場力学の変遷

過去数年間、ヨウ化ナトリウム[131I]市場は、生産と応用の両面で、その状況を再構築する変革的なシフトを経験してきました。企業や研究機関は、製造方法の信頼性と効率を高める先進技術をいち早く導入してきました。加速器ベースと原子炉ベースの技術革新は、品質と安全性を損なうことなく生産時間を大幅に短縮しました。

この変革は、正確な画像診断と標的治療が重要な個別化医療へのシフトにも表れています。この進化は、製造プロセスで中心的な役割を果たす最先端の線形加速器やハドロン加速器への投資に拍車をかけています。同時に、サイクロトロン照射やウラン核分裂炉が効率と安全性の新しい基準に適応することで、伝統的な原子炉ベースの生産が改革されつつあります。

こうしたシフトは、規制の枠組みや、運転プロトコルを継続的に検証し改良する研究の増加によって推進されています。市場は、従来のやり方から、臨床と産業の両方の要求を満たす統合されたハイテク・ソリューションへと着実に移行しています。今日の情勢はダイナミックな変化の時代を反映しており、共同戦略と技術の進歩が、急速に進化する核医学と研究の分野におけるイノベーションと競合優位性の両方を促進しています。

生産、形態、用途、最終用途の各産業におけるセグメンテーションインサイト

ヨウ化ナトリウム[131I]市場の詳細なセグメンテーション分析により、生産、形態、用途、最終用途産業の多面性に対応する複雑な構造が明らかになりました。まず、種類別に見ると、市場は主に2つのカテゴリーで区別される：純粋なヨウ化ナトリウム[131I]と放射性医薬品です。この分類は、製品の二重の性質を強調するものであり、単体の要素としても、多様な治療手順における不可欠な構成要素としても機能します。

製品はカプセル、液体、固体など様々な形態で入手可能であり、それぞれが投与の容易さ、安定性、投与量の正確さに関連した独自の利点を提供しています。製品の形態は、様々な臨床・調査現場の特定の要件を確実に満たす上で極めて重要です。さらに、製造方法も重要なセグメンテーション・パラメーターです。この業界は、加速器ベースの製造とリアクターベースの製造の両方を活用しています。加速器ベースのアプローチは、ハドロン加速器や線形加速器を含むアプリケーションによってさらに洗練され、原子炉ベースの生産はサイクロトロン照射やウラン核分裂炉を活用します。これらの革新的な手法により、製造の拡張性と、進化する規制基準への適応性が確保されます。

生産技術だけでなく、市場は用途によってさらに細分化されます。産業用分野では、放射線遮蔽や放射性トレーサーといったニッチな使用事例に対応しています。一方、医療分野は、特に画像診断、放射性医薬品製造、治療手技における主要な消費者です。さらに、化学合成や核医学研究における研究用途も引き続き市場拡大の原動力となっています。最後に、最終用途産業別にセグメント化することで、学術・研究機関、化学・バイオテクノロジー産業、ヘルスケア・製薬セクター、さらには原子力発電所まで、これらの製品の広範な範囲が浮き彫りになり、ヨウ化ナトリウム[131I]の広範な市場範囲と多様な用途の状況を反映しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腫瘍学における個別化治療アプローチのためのヨウ化ナトリウム[131I]の使用が拡大し、市場の成長を促進
    • 核医学と放射性医薬品技術の進歩により、診断と治療におけるヨウ化ナトリウム[131I]の採用が促進される
    • 甲状腺がん治療における放射性ヨウ素療法のヨウ化ナトリウム[131I]を使用した標的がん治療の必要性の高まり
  • 抑制要因
    • 規制上の課題と、ヨウ化ナトリウム[131I]の製造と取り扱いに関する厳格な安全プロトコルが市場の成長を制限している
  • 機会
    • ヨウ化ナトリウム[131I]への研究開発投資を増やし、治療への応用を強化して患者の転帰を改善する
    • 希少がんに対する新たな放射性ヨウ素ベースの治療法の出現、ヨウ化重点[131I]市場プレーヤーに新たな成長の道を提供
  • 課題
    • 甲状腺機能障害や放射線被曝のリスクなどの潜在的な副作用がヨウ化ナトリウム[131I]療法に関連し、患者の受け入れに影響を与える
• 市場セグメンテーション分析
  • タイプ：がん治療および診断用放射性医薬品におけるヨウ化ナトリウム[131I]の役割
  • 最終用途産業：化学およびバイオテクノロジー産業における医薬品開発と分子イメージングにおけるヨウ化ナトリウム[131I]の重要性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヨウ化ナトリウム[131I]市場：タイプ別

• 純粋なヨウ化ナトリウム[131I]
• 放射性医薬品

第7章 ヨウ化ナトリウム[131I]市場：形態別

• カプセル剤
• 液体
• ソリッドフォーム

第8章 ヨウ化ナトリウム[131I]市場製造方法別

• 加速器ベースの生産
  • ハドロン加速器
  • 線形加速器
• 原子炉ベースの生産
  • サイクロトロン照射
  • ウラン核分裂炉

第9章 ヨウ化ナトリウム[131I]市場：用途別

• 産業
  • 放射線遮蔽
  • 放射性トレーサーの応用
• 医学
  • 診断画像
  • 放射性医薬品製造
  • 治療手順
• 調査
  • 化学合成
  • 核医学調査

第10章 ヨウ化ナトリウム[131I]市場：最終用途産業別

• 学術・調査機関
• 化学およびバイオテクノロジー産業
• ヘルスケア・医薬品
• 原子力発電所

第11章 南北アメリカのヨウ化ナトリウム[131I]市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のヨウ化ナトリウム[131I]市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのヨウ化ナトリウム[131I]市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Cardinal Health, Inc.
• China Isotope & Radiation Corporation
• Curium Pharma
• Eckert & Ziegler Radiopharma GmbH
• GE Healthcare, Inc.
• Institute of Isotopes Co., Ltd.
• International Isotopes Inc.
• Isotope JSC
• Jubilant DraxImage Inc.
• Mallinckrodt Pharmaceuticals
• MEDSNAB LLC
• Nordion Inc.
• NorthStar Medical Technologies, LLC
• NTP Radioisotopes SOC Ltd
• PDRadiopharma Inc.
• Shandong Xinhua Pharma
• Siemens Healthineers AG
• Telix Pharmaceuticals Limited
• Yantai Dongcheng Pharmaceutical Group Co. Ltd.

LIST OF FIGURES

• FIGURE 1. SODIUM IODIDE [131I] MARKET MULTI-CURRENCY
• FIGURE 2. SODIUM IODIDE [131I] MARKET MULTI-LANGUAGE
• FIGURE 3. SODIUM IODIDE [131I] MARKET RESEARCH PROCESS
• FIGURE 4. SODIUM IODIDE [131I] MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. SODIUM IODIDE [131I] MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. SODIUM IODIDE [131I] MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. SODIUM IODIDE [131I] MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SODIUM IODIDE [131I] MARKET DYNAMICS
• TABLE 7. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PURE SODIUM IODIDE [131I], BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CAPSULE FORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY SOLID FORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY HADRON ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CYCLOTRON IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY URANIUM FISSION REACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIATION SHIELDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIOTRACER APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY NUCLEAR MEDICINE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CHEMICAL & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY NUCLEAR ENERGY PLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 73. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 75. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 76. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 77. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 78. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 80. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 81. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 82. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 123. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 124. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 125. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 127. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 128. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 129. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 130. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 132. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 133. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 134. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 135. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 137. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 138. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 139. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 140. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 142. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 143. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 144. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 150. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 152. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 153. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 154. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 159. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 160. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 162. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 163. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 164. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 168. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 169. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 170. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 172. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 173. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 174. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 175. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 177. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 178. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 179. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 180. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 182. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 183. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 184. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 185. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 187. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 188. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 189. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 190. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 192. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 193. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 194. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 205. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 207. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 208. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 209. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 210. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 212. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 213. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 214. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 215. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 217. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 218. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 219. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 220. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 222. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 223. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 224. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 225. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 227. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 228. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 229. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 230. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 232. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 233. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 234. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 246. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 248. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 249. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 250. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 251. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 253. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 254. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 255. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 256. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 258. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 259. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 260. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 261. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 263. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 264. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 265. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 266. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 267. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 268. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 269. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 270. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 271. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 273. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 274. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 275. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 276. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 277. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 278. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 279. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 280. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 281. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 283. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 284. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 285. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 286. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 287. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 288. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 289. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 290. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 291. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 292. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 293. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 294. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 295. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 296. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 297. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 298. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 299. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 300. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 301. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 302. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 303. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 304. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 305. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 306. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 307. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 308. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 309. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 310. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 311. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 312. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 313. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 314. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 315. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 316. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 317. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 318. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 319. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 320. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 321. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 322. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 323. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 324. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 325. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 326. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 327. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 328. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 329. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 330. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 331. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 332. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 333. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 334. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 335. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
• TABLE 336. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 337. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 338. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
• TABLE 339. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 340. NORWAY SODIUM IODID

The Sodium Iodide [131I] Market was valued at USD 736.80 million in 2024 and is projected to grow to USD 779.02 million in 2025, with a CAGR of 5.94%, reaching USD 1,041.82 million by 2030.

Sodium Iodide [131I] plays a pivotal role in modern nuclear medicine and industrial applications, marking a turning point in both therapeutic and diagnostic arenas. As the demand for precision interventions grows, this radioactive isotope has become an essential component in radiopharmaceutical formulations and various research initiatives. Recent advancements in technology and regulatory measures have bolstered the reliability of production methods, ensuring that both quality and safety meet the highest international standards.

In today's dynamic environment, stakeholders are witnessing a transformation that blends traditional methodologies with innovative production techniques. The evolution of Sodium Iodide [131I] is reflective of a broader trend within the industry-a shift toward more efficient, safe, and cost-effective practices that support clinical excellence and industrial reliability. In this comprehensive analysis, we explore the multifaceted roles of Sodium Iodide [131I] in diagnostic imaging, radiotherapeutic procedures, and scientific research. Each development underlines the importance of technological integration and regulatory advancements in maintaining the momentum of industry growth.

Moreover, insights into evolving market dynamics suggest that an integrated approach-combining rigorous quality control with progressive research-can dramatically enhance both the production and application of Sodium Iodide [131I]. This introductory overview provides the necessary context for understanding subsequent analyses on market segmentation, regional trends, and strategic company initiatives.

Transformative Shifts in Production, Application, and Market Dynamics

Over the past few years, the market for Sodium Iodide [131I] has experienced transformative shifts that are reshaping its landscape, both in production and application. Companies and institutions have been quick to adopt advanced technologies which enhance the reliability and efficiency of production methods. Innovations in accelerator-based and reactor-based techniques have significantly reduced production times while ensuring that quality and safety remain uncompromised.

The transformation is also evident in the shift towards personalized medicine, where accurate diagnostic imaging and targeted therapy are critical. This evolution has spurred investments in state-of-the-art linear accelerators and hadron accelerators that play a central role in the production process. Concurrently, traditional reactor-based production is undergoing reformation with cyclotron irradiation and uranium fission reactors adapting to newer standards of efficiency and safety.

These shifts are propelled by regulatory frameworks and a growing body of research that continually validates and refines operational protocols. The market is steadily transitioning from conventional practices towards integrated, high-tech solutions that meet both clinical and industrial demands. Today's landscape reflects an era of dynamic change, where collaborative strategies and technological advancements are driving both innovation and competitive advantage in the rapidly evolving field of nuclear medicine and research.

Segmentation Insights across Production, Form, Application, and End-use Industries

Detailed segmentation analysis of the Sodium Iodide [131I] market reveals a complex structure that caters to multiple facets of production, form, application, and end-user industries. First, when looking at the type, the market is distinguished by two primary categories: Pure Sodium Iodide [131I] and Radiopharmaceuticals. This classification underscores the dual nature of the product, serving as both a standalone element and an integral component in diverse therapeutic procedures.

The product is available in various forms including capsule, liquid, and solid, each offering its own set of benefits related to ease of administration, stability, and dosage accuracy. The form of the product is critical in ensuring that it meets the specific requirements of different clinical and research settings. In addition, the production method is another vital segmentation parameter. The industry capitalizes on both accelerator-based production and reactor-based production. Accelerator-based approaches are further refined by applications involving hadron accelerators and linear accelerators, whereas reactor-based production leverages cyclotron irradiation and uranium fission reactors. These innovative methodologies ensure that production is both scalable and adaptable to evolving regulatory standards.

Beyond production techniques, the market finds further segmentation based on application. The industrial segment addresses niche use-cases such as radiation shielding and radiotracer applications. Meanwhile, the medical sector is a primary consumer, particularly in diagnostic imaging, radiopharmaceutical production, and therapeutic procedures. Additionally, research applications in chemical synthesis and nuclear medicine research continue to drive market expansion. Finally, segmentation by end-use industry highlights the broad scope of these products-from academic and research institutions, chemical and biotechnology industries, to healthcare and pharmaceutical sectors, and even nuclear energy plants, thereby reflecting the extensive market reach and diverse application landscape of Sodium Iodide [131I].

Based on Type, market is studied across Pure Sodium Iodide [131I] and Radiopharmaceuticals.

Based on Form, market is studied across Capsule Form, Liquid Form, and Solid Form.

Based on Production Method, market is studied across Accelerator-Based Production and Reactor-Based Production. The Accelerator-Based Production is further studied across Hadron Accelerators and Linear Accelerators. The Reactor-Based Production is further studied across Cyclotron Irradiation and Uranium Fission Reactors.

Based on Application, market is studied across Industrial, Medical, and Research. The Industrial is further studied across Radiation Shielding and Radiotracer Applications. The Medical is further studied across Diagnostic Imaging, Radiopharmaceutical Production, and Therapeutic Procedures. The Research is further studied across Chemical Synthesis and Nuclear Medicine Research.

Based on End-Use Industry, market is studied across Academic & Research Institutions, Chemical & Biotechnology Industries, Healthcare & Pharmaceuticals, and Nuclear Energy Plants.

Regional Market Trends and Emerging Opportunities

The global landscape of the Sodium Iodide [131I] market is characterized by distinctive regional trends shaped by varying economic, regulatory, and technological factors. In the Americas, the market tends to be driven by robust healthcare infrastructure and significant investments in nuclear medicine. This is complemented by a mature industrial base that ensures steady demand for innovative radiopharmaceuticals.

In the Europe, Middle East & Africa region, regulatory frameworks and strategic partnerships play a definitive role in steering market growth. Here, rigorous quality standards and a commitment to technological advancement enhance the production efficiency and broaden the scope of applications. Meanwhile, the Asia-Pacific region is emerging as a key growth nexus, fueled by rapid industrialization, increasing healthcare expenditure, and collaborative research initiatives. The dynamism in this region is largely attributed to progressive regulatory amendments and heightened awareness regarding advanced diagnostic and therapeutic protocols.

Collectively, these regional insights highlight a diverse yet interlinked global market where localized trends coalesce to create a competitive environment. The evolving regulatory landscape, varying degrees of technological adoption, and growing consumer awareness are converging to promote sustainable growth in each region.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Industry Players Driving Market Innovation

Several key companies are instrumental in driving innovation and pushing the boundaries in the Sodium Iodide [131I] market. Industry leaders such as Cardinal Health, Inc. and China Isotope & Radiation Corporation are recognized for their pioneering production techniques and broad market reach. Firms like Curium Pharma and Eckert & Ziegler Radiopharma GmbH continue to innovate in radiopharmaceutical development, ensuring that advanced medical imaging and therapeutic procedures remain within reach for a global patient base.

Other influential players, including GE Healthcare, Inc. and the Institute of Isotopes Co., Ltd., have established themselves by consistently adhering to high industry standards and leveraging advanced technological infrastructures. The contributions of International Isotopes Inc. and Isotope JSC further illustrate the sector's commitment to quality and innovation. Moreover, companies such as Jubilant DraxImage Inc. and Mallinckrodt Pharmaceuticals have broadened the spectrum of applications by integrating cutting-edge research into their product lines.

Additional market influencers like MEDSNAB LLC, Nordion Inc., NorthStar Medical Technologies, LLC, and NTP Radioisotopes SOC Ltd have expanded offerings in both medical and industrial segments. Key collaborations and strategic investments by PDRadiopharma Inc., Shandong Xinhua Pharma, Siemens Healthineers AG, Telix Pharmaceuticals Limited, and Yantai Dongcheng Pharmaceutical Group Co. Ltd. further consolidate the sector's robust network of expertise, thereby driving the overall momentum and fostering a competitive environment in the global market.

The report delves into recent significant developments in the Sodium Iodide [131I] Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., China Isotope & Radiation Corporation, Curium Pharma, Eckert & Ziegler Radiopharma GmbH, GE Healthcare, Inc., Institute of Isotopes Co., Ltd., International Isotopes Inc., Isotope JSC, Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals, MEDSNAB LLC, Nordion Inc., NorthStar Medical Technologies, LLC, NTP Radioisotopes SOC Ltd, PDRadiopharma Inc., Shandong Xinhua Pharma, Siemens Healthineers AG, Telix Pharmaceuticals Limited, and Yantai Dongcheng Pharmaceutical Group Co. Ltd.. Actionable Recommendations for Strategy and Growth

Industry leaders can unlock significant growth opportunities by implementing actionable strategies that navigate the intricacies of the Sodium Iodide [131I] market. To maintain competitive advantage, companies should consider investing in advanced production technologies that ensure high quality and efficient output, particularly by embracing both accelerator-based and reactor-based methods. These investments will help in optimizing production workflows while reducing operational risks and costs.

In addition, integrating cross-functional collaborations between research institutions, healthcare providers, and industrial partners can foster groundbreaking innovation. Leaders are encouraged to leverage data-driven insights and market segmentation intelligence to tailor products for diverse applications-ranging from diagnostic imaging to industrial radiotracer applications. This multidimensional approach not only enhances product versatility but also addresses the specific needs of different end-user industries including academic, chemical, and pharmaceutical sectors.

Furthermore, capitalizing on emerging regional opportunities is paramount. An agile strategy that adapts to regional regulatory frameworks, consumer preferences, and technology adoption trends can drive market penetration. Companies should also prioritize investments in research and development, focusing on enhancing product efficacy and safety. By cultivating a culture of continuous improvement and innovation, industry leaders can enhance their market positioning, counter competitive pressures, and pave the way for sustainable growth.

Final Thoughts on Market Dynamics and Future Outlook

In summary, the evolution of the Sodium Iodide [131I] market is being driven by technological innovations, evolving regulatory mandates, and comprehensive segmentation strategies that cater to diverse applications. The integration of advanced production methodologies with customized solutions has positioned this market at the forefront of both industrial and medical advancements. Stakeholders now have a clearer roadmap for navigating an increasingly competitive landscape, where adaptability and strategic investments are key.

The concerted efforts by major industry players and regional markets are shaping a future where efficiency, quality, and innovation coalesce to form a robust market framework. This holistic overview not only highlights the current industry dynamics but also sets the stage for future advancements that promise to redefine therapeutic and diagnostic paradigms.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding use of sodium iodide [131I] for personalized treatment approaches in oncology, fueling market growth
    • 5.1.1.2. Growing advancements in nuclear medicine and radiopharmaceutical technologies boosting the adoption of sodium iodide [131I] in diagnostics and treatment
    • 5.1.1.3. Increasing need for targeted cancer therapies using sodium iodide [131I] for radioiodine therapy in thyroid cancer treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Regulatory challenges and strict safety protocols for the manufacturing and handling of sodium iodide [131I] limiting market growth
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing research and development investments in sodium iodide [131I] to enhance its therapeutic applications and improve patient outcomes
    • 5.1.3.2. Emergence of novel radioactive iodine-based therapies for rare cancers, providing new growth avenues for sodium iodide [131I] market players
  • 5.1.4. Challenges
    • 5.1.4.1. Potential side effects such as thyroid dysfunction and radiation exposure risks associated with sodium iodide [131I] therapy, affecting patient acceptance
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Role of sodium iodide [131I] in radiopharmaceuticals for cancer treatment and diagnostics
  • 5.2.2. End-Use Industry: Significance of sodium iodide [131I] in chemical & biotechnology industries for drug development and molecular imaging
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Sodium Iodide [131I] Market, by Type

• 6.1. Introduction
• 6.2. Pure Sodium Iodide [131I]
• 6.3. Radiopharmaceuticals

7. Sodium Iodide [131I] Market, by Form

• 7.1. Introduction
• 7.2. Capsule Form
• 7.3. Liquid Form
• 7.4. Solid Form

8. Sodium Iodide [131I] Market, by Production Method

• 8.1. Introduction
• 8.2. Accelerator-Based Production
  • 8.2.1. Hadron Accelerators
  • 8.2.2. Linear Accelerators
• 8.3. Reactor-Based Production
  • 8.3.1. Cyclotron Irradiation
  • 8.3.2. Uranium Fission Reactors

9. Sodium Iodide [131I] Market, by Application

• 9.1. Introduction
• 9.2. Industrial
  • 9.2.1. Radiation Shielding
  • 9.2.2. Radiotracer Applications
• 9.3. Medical
  • 9.3.1. Diagnostic Imaging
  • 9.3.2. Radiopharmaceutical Production
  • 9.3.3. Therapeutic Procedures
• 9.4. Research
  • 9.4.1. Chemical Synthesis
  • 9.4.2. Nuclear Medicine Research

10. Sodium Iodide [131I] Market, by End-Use Industry

• 10.1. Introduction
• 10.2. Academic & Research Institutions
• 10.3. Chemical & Biotechnology Industries
• 10.4. Healthcare & Pharmaceuticals
• 10.5. Nuclear Energy Plants

11. Americas Sodium Iodide [131I] Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Sodium Iodide [131I] Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Sodium Iodide [131I] Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Sanofi ventures into radiopharmaceuticals with EUR 100 million deal for AlphaMedix
  • 14.3.2. Study by Boston University reveals surgical and radioactive iodine treatments significantly lower cardiovascular risks in hyperthyroid patients
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Cardinal Health, Inc.
• 2. China Isotope & Radiation Corporation
• 3. Curium Pharma
• 4. Eckert & Ziegler Radiopharma GmbH
• 5. GE Healthcare, Inc.
• 6. Institute of Isotopes Co., Ltd.
• 7. International Isotopes Inc.
• 8. Isotope JSC
• 9. Jubilant DraxImage Inc.
• 10. Mallinckrodt Pharmaceuticals
• 11. MEDSNAB LLC
• 12. Nordion Inc.
• 13. NorthStar Medical Technologies, LLC
• 14. NTP Radioisotopes SOC Ltd
• 15. PDRadiopharma Inc.
• 16. Shandong Xinhua Pharma
• 17. Siemens Healthineers AG
• 18. Telix Pharmaceuticals Limited
• 19. Yantai Dongcheng Pharmaceutical Group Co. Ltd.